Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022 BPTH_First_Quarter_2022_Earnings_Announcementdocx
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting BP1003_AACR_2022
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting BPTH_BP1003_AACR-2022
Bio-Path Holdings to Announce Full Year 2021 Financial Results on March 11, 2022 BPTH-Year-End-2021-Earnings-Announcement
Bio-Path Holdings to Present at H.C. Wainwright BioConnect 2022 Virtual Conference BPTH_HCW_Announcement_20220105
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
